Ray; Mitali

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ray; Mitali.The latest application filed is for "herbal composition for treating cd33+ acute and chronic myeloid leukemia and a method thereof".

Company Profile

0.8.12

Ray; Mitali - Calcutta IN
Ray; Mitali - Kolkata IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof Grant 8,029,833 - Bandyopadhyay , et al. October 4, 2	2011-10-04
Herbal Composition For Treating Cd33+ Acute And Chronic Myeloid Leukemia And A Method Thereof App 20100068314 - Bandyopadhyay; Santu ; et al.	2010-03-18
Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof Grant 7,674,487 - Bandyopadhyay , et al. March 9, 2	2010-03-09
In vitro method to generate dendritic Langerhans type cells Grant 7,638,329 - Bandyopadhyay , et al. December 29, 2	2009-12-29
Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof Grant 7,306,817 - Bandyopadhyay , et al. December 11, 2	2007-12-11
Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof App 20070184131 - Bandyopadhyay; Santu ; et al.	2007-08-09
Use of betel leaf extract to induce IFN-gamma production from human peripheral blood T cells and as a Th1 type immunomodulator Grant 7,045,157 - Bandyopadhyay , et al. May 16, 2	2006-05-16
Use of betel leaf extract to induce IFN-gamma production from human peripheral blood T cells and as a Th1 type immunomodulator App 20060013900 - Bandyopadhyay; Santu ; et al.	2006-01-19
Herbal-based composition for treating acute and chronic myeloid leukemia Grant 6,967,034 - Bandyopadhyay , et al. November 22, 2	2005-11-22
Herbal composition for treating CD33and chronic myeloid leukemia and a method thereof App 20050089585 - Bandyopadhyay, Santu ; et al.	2005-04-28
Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof Grant 6,852,344 - Bandyopadhyay , et al. February 8, 2	2005-02-08
Herbal based composition for treating acute and chronic myeloid leukemia App 20040043086 - Bandyopadhyay, Santu ; et al.	2004-03-04
Anti-leishmanial activity of betel leaf extract Grant 6,610,332 - Bandyopadhyay , et al. August 26, 2	2003-08-26
Use of betel leaf extract to induce IFN-gamma production from human peripheral blood T cells and as a Th1 type immunomodulator App 20030108632 - Bandyopadhyay, Santu ; et al.	2003-06-12
Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof App 20030049334 - Bandyopadhyay, Santu ; et al.	2003-03-13
Anti-leishmanial activity of betel leaf extract App 20020150636 - Bandyopadhyay, Santu ; et al.	2002-10-17
Use of betel leaf extract to induce IFN-gamma production from human peripheral blood T cells and as a Th1 type immunomodulator App 20020146470 - Bandyopadhyay, Santu ; et al.	2002-10-10
In vitro method to generate dendritic langerhans type cells App 20020123140 - Bandyopadhyay, Santu ; et al.	2002-09-05
Anti-leishmanial Activity Of Betel Leaf Extract App 20020098251 - Bandyopadhyay, Santu ; et al.	2002-07-25
Antimonocytic activity of betel leaf extracts App 20020068096 - Bandyopadhyay, Santu ; et al.	2002-06-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.